import{_ as e}from"./plugin-vue_export-helper-DlAUqK2U.js";import{ah as o,aj as a,ai as s}from"./app-B1yvyhGf.js";const n={};function r(f,t){return s(),o("div",null,t[0]||(t[0]=[a('<h1 id="王浩宇偷偷od泰诺后不慎睡着了" tabindex="-1"><a class="header-anchor" href="#王浩宇偷偷od泰诺后不慎睡着了"><span>王浩宇偷偷OD泰诺后不慎睡着了</span></a></h1><p>2025年四月下旬，王浩宇在科学课上OD<sup class="footnote-ref"><a href="#footnote1">[1]</a><a class="footnote-anchor" id="footnote-ref1"></a></sup>一颗泰诺后不慎睡着了，原因是泰诺中的马来酸氯苯那敏属于第一代组胺H<sub>1</sub>受体拮抗剂，虽然价格便宜，但是由于其容易透过血脑屏障的特点，容易产生嗜睡等副作用<sup class="footnote-ref"><a href="#footnote2">[2]</a><a class="footnote-anchor" id="footnote-ref2"></a></sup>，因此现在针对变应性鼻炎等过敏症状，临床上的一线用药为第二代H<sub>1</sub>受体拮抗剂，此外还可辅以鼻用糖皮质激素和口服白三烯受体拮抗剂以起到更好的治疗作用<sup class="footnote-ref"><a href="#footnote3">[3]</a><a class="footnote-anchor" id="footnote-ref3"></a></sup><sup class="footnote-ref"><a href="#footnote4">[4]</a><a class="footnote-anchor" id="footnote-ref4"></a></sup>。第二代抗组胺药起效快，作用持续时间较长，能明显缓解鼻部症状，特别是鼻痒，喷嚏和流涕等症状<sup class="footnote-ref"><a href="#footnote5">[5]</a><a class="footnote-anchor" id="footnote-ref5"></a></sup><sup class="footnote-ref"><a href="#footnote6">[6]</a><a class="footnote-anchor" id="footnote-ref6"></a></sup><sup class="footnote-ref"><a href="#footnote7">[7]</a><a class="footnote-anchor" id="footnote-ref7"></a></sup><sup class="footnote-ref"><a href="#footnote8">[8]</a><a class="footnote-anchor" id="footnote-ref8"></a></sup>。</p><hr class="footnotes-sep"><section class="footnotes"><ol class="footnotes-list"><li id="footnote1" class="footnote-item"><p>即Overdose，缩写OD，严格译作过度剂量，即过量，并不带药物滥用的含义，滥用药物对应的英文是Drug abuse。<span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext>OD</mtext><mo>⫋</mo><mtext>药物滥用</mtext></mrow><annotation encoding="application/x-tex">\\text{OD}\\subsetneqq\\text{药物滥用}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1.0786em;vertical-align:-0.2848em;"></span><span class="mord text"><span class="mord">OD</span></span><span class="mspace" style="margin-right:0.2778em;"></span><span class="mrel amsrm">⫋</span><span class="mspace" style="margin-right:0.2778em;"></span></span><span class="base"><span class="strut" style="height:0.6833em;"></span><span class="mord text"><span class="mord cjk_fallback">药物滥用</span></span></span></span></span>，即药物滥用包括但不限于OD。 <a href="#footnote-ref1" class="footnote-backref">↩︎</a></p></li><li id="footnote2" class="footnote-item"><p>上海强生制药有限公司.酚麻美敏片. <a href="#footnote-ref2" class="footnote-backref">↩︎</a></p></li><li id="footnote3" class="footnote-item"><p>程雷.变应性鼻炎治疗中应关注的几个临床问题[J].中华耳鼻咽喉头颈外科杂志, 2020, 55(5): 437-439. DOI: <a href="https://doi.org/10.3760/cma.j.cn115330-20200323-00230" target="_blank" rel="noopener noreferrer">10.3760/cma.j.cn115330-20200323-00230</a>. <a href="#footnote-ref3" class="footnote-backref">↩︎</a></p></li><li id="footnote4" class="footnote-item"><p>李华斌,王向东,王洪田,等.口服H1抗组胺药治疗变应性鼻炎2018广州共识[J].中国眼耳鼻喉科杂志,2018,18(3):149-156. DOI: <a href="https://doi.org/10.14166/j.issn.1671-2420.2018.03.001" target="_blank" rel="noopener noreferrer">10.14166/j.issn.1671-2420.2018.03.001</a>. <a href="#footnote-ref4" class="footnote-backref">↩︎</a></p></li><li id="footnote5" class="footnote-item"><p>Wheatley LM, Togias A. Clinical practice. Allergic rhinitis[J]. N Engl J Med, 2015, 372(5): 456-463. DOI: <a href="https://doi.org/10.1056/NEJMcp1412282" target="_blank" rel="noopener noreferrer">10.1056/NEJMcp1412282</a>. <a href="#footnote-ref5" class="footnote-backref">↩︎</a></p></li><li id="footnote6" class="footnote-item"><p>Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)[J]. Allergy, 2008, 63 Suppl 86: 8-160. DOI: <a href="https://doi.org/10.1111/j.1398-9995.2007.01620.x" target="_blank" rel="noopener noreferrer">10.1111/j.1398-9995.2007.01620.x</a>. <a href="#footnote-ref6" class="footnote-backref">↩︎</a></p></li><li id="footnote7" class="footnote-item"><p>Okubo K, Kurono Y, Fujieda S, et al. Japanese Guideline for Allergic Rhinitis 2014[J]. Allergol Int, 2014, 63(3):357-375. DOI: <a href="https://doi.org/10.2332/allergolint.14-RAI-0768" target="_blank" rel="noopener noreferrer">10.2332/allergolint.14-RAI-0768</a>. <a href="#footnote-ref7" class="footnote-backref">↩︎</a></p></li><li id="footnote8" class="footnote-item"><p>中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南（2022年，修订版）[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57 (2): 106-129. DOI: <a href="https://doi.org/10.3760/cma.j.cn115330-20211228-00828" target="_blank" rel="noopener noreferrer">10.3760/cma.j.cn115330-20211228-00828</a>. <a href="#footnote-ref8" class="footnote-backref">↩︎</a></p></li></ol></section>',4)]))}const l=e(n,[["render",r]]),p=JSON.parse(`{"path":"/post/WHYODTylenol.html","title":"王浩宇偷偷OD泰诺后不慎睡着了","lang":"zh-CN","frontmatter":{"date":"2025-07-22T00:00:00.000Z","category":["奇闻轶事","科学"],"tag":["王浩宇","药物滥用","OD","变应性鼻炎","过敏","医药"],"icon":"pills","description":"王浩宇偷偷OD泰诺后不慎睡着了 2025年四月下旬，王浩宇在科学课上OD[1]一颗泰诺后不慎睡着了，原因是泰诺中的马来酸氯苯那敏属于第一代组胺H1受体拮抗剂，虽然价格便宜，但是由于其容易透过血脑屏障的特点，容易产生嗜睡等副作用[2]，因此现在针对变应性鼻炎等过敏症状，临床上的一线用药为第二代H1受体拮抗剂，此外还可辅以鼻用糖皮质激素和口服白三烯受体拮抗...","head":[["script",{"type":"application/ld+json"},"{\\"@context\\":\\"https://schema.org\\",\\"@type\\":\\"Article\\",\\"headline\\":\\"王浩宇偷偷OD泰诺后不慎睡着了\\",\\"image\\":[\\"\\"],\\"datePublished\\":\\"2025-07-22T00:00:00.000Z\\",\\"dateModified\\":\\"2025-08-16T09:46:25.000Z\\",\\"author\\":[{\\"@type\\":\\"Person\\",\\"name\\":\\"Silentnrtx\\",\\"url\\":\\"https://chinasd1st.github.io\\"}]}"],["meta",{"property":"og:url","content":"https://chinasd1st.github.io/post/WHYODTylenol.html"}],["meta",{"property":"og:site_name","content":"小奶奶博客"}],["meta",{"property":"og:title","content":"王浩宇偷偷OD泰诺后不慎睡着了"}],["meta",{"property":"og:description","content":"王浩宇偷偷OD泰诺后不慎睡着了 2025年四月下旬，王浩宇在科学课上OD[1]一颗泰诺后不慎睡着了，原因是泰诺中的马来酸氯苯那敏属于第一代组胺H1受体拮抗剂，虽然价格便宜，但是由于其容易透过血脑屏障的特点，容易产生嗜睡等副作用[2]，因此现在针对变应性鼻炎等过敏症状，临床上的一线用药为第二代H1受体拮抗剂，此外还可辅以鼻用糖皮质激素和口服白三烯受体拮抗..."}],["meta",{"property":"og:type","content":"article"}],["meta",{"property":"og:locale","content":"zh-CN"}],["meta",{"property":"og:updated_time","content":"2025-08-16T09:46:25.000Z"}],["meta",{"property":"article:tag","content":"医药"}],["meta",{"property":"article:tag","content":"过敏"}],["meta",{"property":"article:tag","content":"变应性鼻炎"}],["meta",{"property":"article:tag","content":"OD"}],["meta",{"property":"article:tag","content":"药物滥用"}],["meta",{"property":"article:tag","content":"王浩宇"}],["meta",{"property":"article:published_time","content":"2025-07-22T00:00:00.000Z"}],["meta",{"property":"article:modified_time","content":"2025-08-16T09:46:25.000Z"}]]},"git":{"createdTime":1753181075000,"updatedTime":1755337585000,"contributors":[{"name":"Chinasd1st","username":"Chinasd1st","email":"1297537384@qq.com","commits":7,"url":"https://github.com/Chinasd1st"}],"changelog":[{"hash":"d1bf74892821bd2717953ad581d622f42b20c8c1","time":1755337585000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"更新参考文献格式，添加DOI链接以增强文献的可追溯性"},{"hash":"3290d337a87116aafdd1bb178f41347883caa4b1","time":1755337076000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"更新样式以支持深色和浅色模式下的Aplayer，为DOI增加超链接"},{"hash":"f6c0befedd78da46c1a883285ed138134d15ca0c","time":1755335053000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"Add icons to the navigation bar and related content, and update the metadata of multiple articles to include icons."},{"hash":"90d3ea3ea8927b8e5fed99dd60c7be1fdfa53f07","time":1755172624000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"sub"},{"hash":"4175e858cf7ef5ba10be8af1cfcc557641e6584a","time":1754466826000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"Please enter the commit message for your changes. Lines starting   with ' ' will be ignored, and an empty message aborts the commit."},{"hash":"d61df2cc40ae422f2cf003b68f25ef8a6c5867b4","time":1754381514000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"modified:   src/post/LCYBilibiliFavoritesStatistics.md \\tmodified:   src/post/WHYODTylenol.md"},{"hash":"36e3da272cfe14c629f580f7b07f9f4964160fbf","time":1753181075000,"email":"1297537384@qq.com","author":"Chinasd1st","message":"Add WHYODTylenol, fix some problems"}]},"readingTime":{"minutes":2.07,"words":620},"filePathRelative":"post/WHYODTylenol.md","excerpt":"\\n<p>2025年四月下旬，王浩宇在科学课上OD<sup class=\\"footnote-ref\\"><a href=\\"#footnote1\\">[1]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref1\\"></a></sup>一颗泰诺后不慎睡着了，原因是泰诺中的马来酸氯苯那敏属于第一代组胺H<sub>1</sub>受体拮抗剂，虽然价格便宜，但是由于其容易透过血脑屏障的特点，容易产生嗜睡等副作用<sup class=\\"footnote-ref\\"><a href=\\"#footnote2\\">[2]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref2\\"></a></sup>，因此现在针对变应性鼻炎等过敏症状，临床上的一线用药为第二代H<sub>1</sub>受体拮抗剂，此外还可辅以鼻用糖皮质激素和口服白三烯受体拮抗剂以起到更好的治疗作用<sup class=\\"footnote-ref\\"><a href=\\"#footnote3\\">[3]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref3\\"></a></sup><sup class=\\"footnote-ref\\"><a href=\\"#footnote4\\">[4]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref4\\"></a></sup>。第二代抗组胺药起效快，作用持续时间较长，能明显缓解鼻部症状，特别是鼻痒，喷嚏和流涕等症状<sup class=\\"footnote-ref\\"><a href=\\"#footnote5\\">[5]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref5\\"></a></sup><sup class=\\"footnote-ref\\"><a href=\\"#footnote6\\">[6]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref6\\"></a></sup><sup class=\\"footnote-ref\\"><a href=\\"#footnote7\\">[7]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref7\\"></a></sup><sup class=\\"footnote-ref\\"><a href=\\"#footnote8\\">[8]</a><a class=\\"footnote-anchor\\" id=\\"footnote-ref8\\"></a></sup>。</p>","autoDesc":true}`);export{l as comp,p as data};
